Literature DB >> 33877454

The association of polymorphisms in TNF and ankylosing spondylitis in common population: a meta-analysis.

Huae Shu1, Hongsheng Sun2,3, Naiwen Hu4,5, Xi Chen6, Shanjuan Wang6, Gangying Yuan6, Qinqin Wang6.   

Abstract

BACKGROUND: Studies investigating the association between the polymorphisms in TNF and ankylosing spondylitis have been reported the conflicting results. Here we performed a meta-analysis based on the evidence available from the literature up-to-date to further clarify this relationship.
METHODS: Our systematic search was done in the PubMed, Embase and Cochrane databases (up to March 2020). The pooled and individual odds ratios (ORs) with 95% confidence intervals (CIs) of the minor allele of each locus were presented to assess the associations between TNF polymorphisms and AS in different ethnicities in common population.
RESULTS: Seventeen studies, consisting of seven European studies, eight East Asian studies and two Latin-American studies, were included in this meta-analysis. In the total population, the A allele in TNF-238 (OR = 0.702, 95%CI = 0.506-0.973, p = 0.034) and TNF-308 (OR = 0.638, 95%CI = 0.507-0.804, p = 0.000), the C allele in TNF-1031 (OR = 0.594, 95%CI = 0.446-0.791, p = 0.000), the T allele in TNF-850 (OR = 3.462, 95%CI = 1.764-6.798, p = 0.000) and rs769178 (OR = 2.593, 95%CI = 2.175-3.091, p = 0.000) were significantly associated with AS susceptibility. There were no significant association between the minor alleles of TNF-376, TNF-857, TNF-863 and AS susceptibility. There are inconsistent results in the Latin-American population and East Asian population with those in the total population.
CONCLUSIONS: Our meta-analysis suggests that TNF-α polymorphisms at positions - 238, - 308, - 850, - 1031 and rs769178 could have an influence on ankylosing spondylitis susceptibility in the total population. But there is no association of the TNF-376, TNF-857, TNF-863 polymorphisms with ankylosing spondylitis. Some results in the subgroups are not consistent with those in the total population.

Entities:  

Keywords:  Ankylosing spondylitis; Meta-analysis; Polymorphisms; TNF

Year:  2021        PMID: 33877454     DOI: 10.1007/s00586-021-06845-w

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  30 in total

1.  Interethnic studies of TNF polymorphisms confirm the likely presence of a second MHC susceptibility locus in ankylosing spondylitis.

Authors:  A Milicic; F Lindheimer; S Laval; M Rudwaleit; H Ackerman; P Wordsworth; T Hohler; M A Brown
Journal:  Genes Immun       Date:  2000-10       Impact factor: 2.676

2.  The association between TNF-alpha promoter polymorphisms and ankylosing spondylitis: a meta-analysis.

Authors:  Bing Li; Pei Wang; Hui Li
Journal:  Clin Rheumatol       Date:  2010-06-11       Impact factor: 2.980

Review 3.  Systematic review or meta-analysis? Their place in the evidence hierarchy.

Authors:  M Paul; L Leibovici
Journal:  Clin Microbiol Infect       Date:  2014-02       Impact factor: 8.067

4.  Tumor necrosis factor gene polymorphisms in ankylosing spondylitis.

Authors:  A Fraile; A Nieto; Y Beraún; J Vinasco; L Matarán; J Martín
Journal:  Tissue Antigens       Date:  1998-04

5.  TNF-238A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients.

Authors:  S González; J C Torre-Alonso; J Martínez-Borra; J A Fernández Sánchez; A López-Vazquez; A Rodríguez Pérez; C López-Larrea
Journal:  J Rheumatol       Date:  2001-06       Impact factor: 4.666

6.  Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with spondyloarthritis.

Authors:  Gilberto Vargas-Alarcón; Julio Casasola-Vargas; José Manuel Rodríguez-Pérez; Gabriela Huerta-Sil; Nonanzit Pérez-Hernández; John Londoño; Cesar Pacheco-Tena; Mario H Cardiel; Julio Granados; Rubén Burgos-Vargas
Journal:  Hum Immunol       Date:  2006-08-22       Impact factor: 2.850

7.  Restriction fragment length polymorphism of the tumor necrosis factor region in patients with ankylosing spondylitis.

Authors:  G M Verjans; S M van der Linden; G J van Eys; L P de Waal; A Kijlstra
Journal:  Arthritis Rheum       Date:  1991-04

8.  The association between tumor necrosis factor alpha promoter polymorphisms and ankylosing spondylitis: a meta-analysis.

Authors:  Bo Ma; Bing Yang; Hainiu Guo; Yihong Wang; Dayi Zhang; Yuan Zhang; Zhengquan Xiao
Journal:  Hum Immunol       Date:  2013-07-02       Impact factor: 2.850

9.  Polymorphism of tumour necrosis factor-alpha (TNF-alpha) at position -308 in relation to ankylosing spondylitis.

Authors:  G M Verjans; B M Brinkman; C E Van Doornik; A Kijlstra; C L Verweij
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

Review 10.  Recent advances in ankylosing spondylitis: understanding the disease and management.

Authors:  Leticia Garcia-Montoya; Hanna Gul; Paul Emery
Journal:  F1000Res       Date:  2018-09-21
View more
  4 in total

1.  [Hyperactivation of PI3K/AKT/mTOR signal pathway impairs TNF-α-induced autophagy in mesenchymal stem cells from patients with ankylosing spondylitis].

Authors:  Z Liu; S Min; X Lu; S Cen; Z Chen; T Wang; J Li; W Zeng; S Qiu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-02-20

2.  The Associations of rs1799724 and rs361525 With the Risk of Ankylosing Spondylitis Are Dependent on HLA-B27 Status in a Chinese Han Population.

Authors:  Nan Sheng; Yingying Gao; Hui Li; Wenwen Wang; Linyu Geng; Bo Zhang; Qiang Huang; Xueqin Wang; Lingyun Sun
Journal:  Front Immunol       Date:  2022-04-05       Impact factor: 8.786

3.  Searching for New Genetic Biomarkers of Axial Spondyloarthritis.

Authors:  Bartosz Bugaj; Joanna Wielińska; Katarzyna Bogunia-Kubik; Jerzy Świerkot
Journal:  J Clin Med       Date:  2022-05-20       Impact factor: 4.964

Review 4.  The Potential Role of Genetics, Environmental Factors, and Gut Dysbiosis in the Aberrant Non-Coding RNA Expression to Mediate Inflammation and Osteoclastogenic/Osteogenic Differentiation in Ankylosing Spondylitis.

Authors:  Hsien-Tzung Liao; Chang-Youh Tsai; Chien-Chih Lai; Song-Chou Hsieh; Yi-Syuan Sun; Ko-Jen Li; Chieh-Yu Shen; Cheng-Han Wu; Cheng-Hsun Lu; Yu-Min Kuo; Tzu-Hao Li; Chung-Tei Chou; Chia-Li Yu
Journal:  Front Cell Dev Biol       Date:  2022-01-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.